
First Patients Treated Using the LV Y-90 Disc and iWand A!
First patients are treated using the LV Y-90 Disc and iWand A.

First patients are treated using the LV Y-90 Disc and iWand A.

Northwell depth-dose study to be presented at the AAPM annual meeting.

Pilot production begins at Liberty Vision.

Liberty Vision CEO Dr. Paul T. Finger contributes to a new book on surgical ophthalmic oncology.
Liberty Vision secures larger facilities to support growing operations.

Testing and qualification of device production and processes is underway.